AIFA – Biosimilari: prove di efficacia e real-world data ne confermano l’intercambiabilità
13/12/2018
Leggi
Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden
Svanström H, Ueda P, Melbye M, et al.
The Lancet Diabetes and Endocrinology. Published online, 5 December 2018
Leggi
Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study
Abrahami D, Douros A, Yin H, et al.
BMJ. 2018;363:k4880
Leggi
GLP-1 receptor agonists and cardiovascular risk in routine clinical practice
Schernthaner G, Schernthaner-Reiter MH
The Lancet Diabetes and Endocrinology. Published online, 5 December 2018
Leggi
Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial
Dodd JM, Louise J, Deussen AR, et al.
The Lancet Diabetes and Endocrinology. Published online, 4 December 2018
Leggi
Trajectories of childhood BMI and adult diabetes: the Bogalusa Heart Study
Zhang T, Xu J, Li S, et al.
Diabetologia. 2019;62(1):70-7
Leggi
Global trends in diabetes complications: a review of current evidence
Harding JL, Pavkov ME, Magliano DJ, et al.
Diabetologia. 2019;62(1):3-16
Leggi
A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study
Gæde J, Oellgaard J, Ibsen R, et al.
Diabetologia. 2019,62(1):147-55
Leggi
Association of long-term child growth and developmental outcomes with metformin vs insulin treatment for gestational diabetes
Landi SN, Radke S, Engel SM, et al.
JAMA Pediatr. Published online, 3 December 2018.
Leggi
Comparison of outcomes in patients with diabetes mellitus treated with versus without insulin + heart failure with preserved left ventricular ejection fraction (from the TOPCAT study)
Huynh T, Harty BJ, Claggett B, et al.
The American Journal of Cardiology. Published online, 24 November 2018.
Leggi